Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)
Stopped Slow recruitment in stratum 3: enrolled only 2 instead of 8 pts. within predicted time
Conditions
- Non-Small Cell Lung Carcinoma
Interventions
- BIOLOGICAL: CV9202
- RADIATION: local radiation
Sponsor
CureVac